Assignee
REXAHN CORP
US·3 granted patents·35 citations·filing 2003–2005
Top patents by PatentIndex Score
3 records- 0187US7405214B2Nucleoside derivatives and therapeutic use thereofREXAHN CORP·Filed 2005·Granted Jul 29, 2008·14 cites·18 claims
- 0273US7122527B2Use of antisense oligonucleotides to inhibit the expression of human Akt-1REXAHN CORP·Filed 2003·Granted Oct 17, 2006·12 cites·20 claims
- 0372US7205283B2Antisense oligonucleotides that inhibit expression of HIF-1REXAHN CORP·Filed 2004·Granted Apr 17, 2007·9 cites·5 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →